Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cordyceps Sunshine Biotech Holdings is a biotechnology company specializing in the research, cultivation, and commercialization of Cordyceps sinensis, a highly valued medicinal fungus in traditional Chinese medicine. The company utilizes advanced fermentation and cultivation technologies to produce high-quality Cordyceps products for the health and wellness market. Its business model encompasses the entire value chain, from laboratory research and large-scale production to the distribution of dietary supplements and functional foods. Headquartered in China with international corporate structures, the company aims to standardize Cordyceps production to meet global healthcare demands. The company's primary offerings include Cordyceps powders, capsules, and functional beverages designed to enhance immune function and overall vitality.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cordyceps Sunshine Biotech Holdings.